• IRP2, TFEB, and Macrophage Antimicrobial Defense

  2026-11-13

  Published mouse, cellular, and human-tissue findings connect IRP2 loss with impaired lysosomal function, defective macrophage bacterial clearance, and liver abscess susceptibility after intestinal barrier injury. The evidence supports a macrophage-centered mechanism involving HIF2α, lactate, and TFEB, while leaving cell-type specificity and clinical causality unresolved.

• What p53 mRNA–LNP Evidence Shows

  2026-11-13

  A 2025 review supports lipid nanoparticles as a plausible carrier platform for nucleic-acid cancer therapies, but p53 mRNA evidence remains mainly preclinical, context-dependent, and insufficient to establish product-specific or clinical efficacy.

• How Azido-PEG6-alcohol Connects Molecular Handles

  2026-11-12

  Azido-PEG6-alcohol is best understood as a PEG-based linker whose azide group enables two conceptually distinct click-chemistry pathways. The documented chemistry supports interpretation of its molecular connectivity, but not conclusions about conversion, stability, biological performance, or any particular conjugate.

• What High-Fidelity PCR Can Show in Nanomedicine

  2026-11-12

  A mechanistic reading of a calcium-lactate bufalin–CRISPR nanomedicine study, separating PCR measurement fidelity from evidence for delivery, cell death, gene editing, immune remodeling, and antitumor activity.

• How Citrulline Shapes Pathway Readouts

  2026-11-11

  Citrulline is best interpreted as a pathway intermediate rather than a standalone marker of one biological outcome. Its meaning depends on whether a measurement reflects urea-cycle conversion, arginine regeneration, nitric-oxide metabolism, or simple abundance in a particular biological compartment.

• When Fluorescence Changes a Repair Result

  2026-11-11

  A fluorescent signal, an interaction map, and a cellular rescue experiment answer different scientific questions. In replication-stressed cells, the meaning of a result depends on whether the readout reports molecular presence, proximity, assembly, or function.

• How Condensate Coronas Enable Biomolecule Transfer

  2026-11-10

  A mechanistic interpretation of how rare nanoparticle–condensate hybrids acquire, protect and transfer proteins and RNAs, with emphasis on causal evidence, measurement limits and applicability.

• How Condensate Coronas Move RNA Between Cells

  2026-11-10

  A Nature Materials study describes rare nanoparticle–cell hybrids that acquire biomolecular condensates, are re-exported, and deliver intact proteins and RNAs to recipient-cell compartments. Its strongest contribution is mechanistic: the condensate appears to regulate endosomal release and intracellular access, although event frequency, particle-to-particle heterogeneity, and broader biological applicability remain uncertain.

• What Rare Particle Complexes Actually Show

  2026-11-09

  A recent study describes rare nanoparticle–condensate hybrids that can carry proteins and RNA between cells. Its strongest evidence concerns particle composition, intracellular trafficking and reporter activity; broader claims about physiological relevance, generality and delivery performance remain unresolved.

• Condensate Coronas and Intercellular RNA Transfer

  2026-11-09

  A Nature Materials study describes rare nanoparticle–condensate hybrids that acquire cell-derived proteins and RNAs, are re-exported, and deliver cargo to other cells. The evidence supports a mechanistic model for privileged intracellular access, while leaving the prevalence, cargo heterogeneity, and broader applicability of the process unresolved.

• NHE1, Calcium, and Macrophage Atherosclerosis

  2026-11-08

  A mouse and macrophage study supports a mechanistic link between octanal/Olfr2 signaling, NHE1 dysregulation, calcium- and ROS-associated responses, and atherosclerotic lesion severity. The evidence is directionally consistent across tissue, cellular, pharmacological, and genetic measurements, but the precise ordering of calcium signaling, NHE1 activation, and inflammasome engagement remains unresolved.

• How Condensate Coronas Transfer RNA Between Cells

  2026-11-07

  A Nature Materials study describes rare hybrid nanoparticle complexes that acquire cell-derived biomolecular condensates, are re-exported, and deliver intact proteins and RNAs to recipient cells. The findings clarify how intracellular processing, condensate composition, and endosomal interactions may govern access to the cytosol and nucleus, while leaving important questions about prevalence and generality unresolved.

• How Condensate Coronae Enable Cellular Cargo Transfer

  2026-11-06

  A published study describes rare nanoparticle–condensate hybrids that carry proteins and RNAs between cells. Its strongest evidence connects particle composition, endosomal behavior and reporter-based function, while leaving the initiating recognition event, quantitative efficiency and physiological generality unresolved.

• How Condensate Coronas Transfer RNA Between Cells

  2026-11-06

  A recent study describes a rare class of nanoparticle–biomolecular condensate complexes that can carry intact proteins and RNAs between cells. The findings clarify how a cell-derived condensate layer may support extracellular stability, endosomal release and cytosolic access, while also defining important limits on how broadly the mechanism can be generalized.

• How Condensate Coronas Enable Cellular Cargo Transfer

  2026-11-05

  A literature-focused analysis of how rare nanoparticle–condensate complexes acquire cellular biomolecules, move between cells, and provide evidence for intracellular access without establishing a general delivery platform.

8135 records 1/543 page Next 12345 下5页 Last page